← Back to Search

CDS + HHFNC Weaning for Bronchiolitis (REST EEC Trial)

N/A

Recruiting

Led By Christopher Horvat, MD

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

<2 years of age Bronchiolitis WOB Score >2

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up days from being off hfnc until oral intake

Awards & highlights

REST EEC Trial Summary

This trial aims to improve recovery from common pediatric respiratory illnesses, reduce costs, and show UPMC Children's Hospital's capabilities in pediatric healthcare. It will examine using CDS to improve adherence to standardized guidelines and outcomes.

Who is the study for?

This trial is for children under 2 years old with bronchiolitis and a work of breathing (WOB) score greater than 2. It's not suitable for kids with congenital heart disease affecting their breathing, those who have weakened immune systems, or chronic lung conditions.Check my eligibility

What is being tested?

The study tests if using Clinical Decision Support (CDS) can help doctors better follow guidelines when starting and adjusting heated high flow nasal cannula (HHFNC) therapy in young patients with bronchiolitis to improve recovery outcomes.See study design

What are the potential side effects?

While the trial focuses on treatment management rather than medication side effects, HHFNC may cause nasal discomfort or irritation, dryness of the airways, or possible difficulty in weaning off due to dependency.

REST EEC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My child is under 2 years old with a severe breathing difficulty score over 2.

REST EEC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ days of care from admission to 90 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~days of care from admission to 90 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and days of care from admission to 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

HFNC duration

Secondary outcome measures

90-day cost of care

Cost of hospitalization

Hospital length of stay

+5 more

REST EEC Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: HHFNC + Clinical decision SupportExperimental Treatment2 Interventions

Standardized HHFNC weaning coupled with clinical decision support consisting of electronic record embedded reminders to the clinical team to wean HHFNC

Group II: HHFNC WeaningActive Control2 Interventions

Team does not receive clinical decision support reminders to wean the HHFNC

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Beckwith FoundationUNKNOWN

1 Previous Clinical Trials

8 Total Patients Enrolled

University of PittsburghLead Sponsor

1,723 Previous Clinical Trials

16,342,958 Total Patients Enrolled

1 Trials studying Bronchiolitis

600 Patients Enrolled for Bronchiolitis

Christopher HorvatLead Sponsor

Media Library

HHFNC + Clinical decision Support Clinical Trial Eligibility Overview. Trial Name: NCT05909566 — N/A

Bronchiolitis Research Study Groups: HHFNC + Clinical decision Support, HHFNC Weaning

Bronchiolitis Clinical Trial 2023: HHFNC + Clinical decision Support Highlights & Side Effects. Trial Name: NCT05909566 — N/A

HHFNC + Clinical decision Support 2023 Treatment Timeline for Medical Study. Trial Name: NCT05909566 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this trial still open at present?

"As per clinicaltrials.gov, this study is not currently seeking participants; it was posted on June 1st 2023 and last updated on the 11th of June 2023. However, there are 40 other trials actively enrolling patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Respiratory Support and Treatment for Efficient and Cost-Effective Care

Christopher Horvat 2023. "Respiratory Support and Treatment for Efficient and Cost-Effective Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05909566.

All > Bronchiolitis